247 related articles for article (PubMed ID: 8372516)
1. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
[No Abstract] [Full Text] [Related]
2. Radioimmunotherapy of solid tumors: from fairytale to reality.
Adams GP; Weiner LM
Cancer Biother Radiopharm; 2001 Feb; 16(1):9-11. PubMed ID: 11279802
[No Abstract] [Full Text] [Related]
3. Two-phase radioimmunotherapy using bispecific monoclonal antibodies (bs MAbs).
Bosslet K; Hermentin P; Kuhlmann L; Steinstraesser A; Seemann G; Sedlacek HH
Cancer Treat Rev; 1990 Sep; 17(2-3):355-6. PubMed ID: 2272051
[No Abstract] [Full Text] [Related]
4. Therapy and imaging of pancreatic carcinoma xenografts with radioiodine-labeled chimeric monoclonal antibody A10 and its Fab fragment.
Kamigaki T; Yamamoto M; Ohyanagi H; Ohya M; Shimazoe T; Kono A; Ohtani W; Narita Y; Ohkubo M; Saitoh Y
Jpn J Cancer Res; 1995 Dec; 86(12):1216-23. PubMed ID: 8636013
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
6. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs.
Stein R; Juweid M; Mattes MJ; Goldenberg DM
Cancer Biother Radiopharm; 1999 Feb; 14(1):37-47. PubMed ID: 10850286
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: prospects for cancer imaging and therapy.
Goldenberg DM
Tumour Biol; 1995; 16(1):62-73. PubMed ID: 7863224
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody.
Kramer EL; DeNardo SJ; Liebes L; Noz ME; Kroger L; Glenn SD; Furmanski P; Ceriani R
Adv Exp Med Biol; 1994; 353():181-92. PubMed ID: 7985537
[No Abstract] [Full Text] [Related]
10. Humanized anti-carcinoembryonic antigen antibody: strategies to enhance human tumor cell killing.
Kaulen H; Seemann G; Bosslet K; Schwaeble W; Dippold W
Year Immunol; 1993; 7():106-9. PubMed ID: 8372499
[No Abstract] [Full Text] [Related]
11. Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.
Crow DM; Williams L; Colcher D; Wong JY; Raubitschek A; Shively JE
Bioconjug Chem; 2005; 16(5):1117-25. PubMed ID: 16173788
[TBL] [Abstract][Full Text] [Related]
12. Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.
Kraeber-Bodéré F; Faibre-Chauvet A; Saï-Maurel C; Gautherot E; Fiche M; Campion L; Le Boterff J; Barbet J; Chatal JF; Thédrez P
J Nucl Med; 1999 Jan; 40(1):198-204. PubMed ID: 9935077
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma.
Kranenborg MH; Boerman OC; Oosterwijk-Wakka JC; de Weijert MC; Corstens FH; Oosterwijk E
Cancer Res; 1995 Dec; 55(23 Suppl):5864s-5867s. PubMed ID: 7493361
[TBL] [Abstract][Full Text] [Related]
14. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
[TBL] [Abstract][Full Text] [Related]
15. Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy.
Li M; Meares CF; Salako Q; Kukis DL; Zhong GR; Miers L; DeNardo SJ
Cancer Res; 1995 Dec; 55(23 Suppl):5726s-5728s. PubMed ID: 7493335
[TBL] [Abstract][Full Text] [Related]
16. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen.
Ayala M; Dueñas M; Santos A; Vázquez J; Menéndez A; Silva A; Gavilondo JV
Biotechniques; 1992 Nov; 13(5):790-9. PubMed ID: 1418981
[TBL] [Abstract][Full Text] [Related]
17. Engineering mouse monoclonal antibodies for cancer immunotherapy.
Orlandi R
Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
[No Abstract] [Full Text] [Related]
18. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
[TBL] [Abstract][Full Text] [Related]
19. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
[TBL] [Abstract][Full Text] [Related]
20. [Radioimmunodetection of 188Re-labeled anti-carcinoembryonic antigen chimeric antibody in nude mice bearing human colon carcinoma].
Zhao ZG; Ran YL; Zheng R; Kong J; Chen SZ; Yu L; Yang ZH
Ai Zheng; 2002 May; 21(5):460-3. PubMed ID: 12452032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
